MacroGenics
MGNX
#8477
Rank
S$0.27 B
Marketcap
S$4.40
Share price
2.99%
Change (1 day)
197.96%
Change (1 year)

MacroGenics (MGNX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$0.25 Billion

According to MacroGenics's latest financial reports the company's total liabilities are S$0.25 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

MacroGenics - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$0.19 B2.77%
2023-12-31S$0.19 B3.75%
2022-12-31S$0.18 B43.58%
2021-12-31S$0.12 B17.94%
2020-12-31S$0.10 B-0.69%
2019-12-31S$0.11 B-9.48%
2018-12-31S$0.12 B22.13%
2017-12-31S$99.83 M62.26%
2016-12-31S$61.52 M-5.3%
2015-12-31S$64.97 M-6.52%
2014-12-31S$69.5 M17.05%
2013-12-31S$59.38 M-21.66%
2012-12-31S$75.8 M-26.99%
2011-12-31S$0.10 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
S$154.78 B 59,471.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$109.58 B 42,077.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$104.47 B 40,107.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$46.42 B 17,766.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$107.37 B 41,224.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$91.21 B 35,005.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
S$0.30 B 17.74%๐Ÿ‡บ๐Ÿ‡ธ USA